Bright Green Corporation (OTCPK: BGXX.Q)
Health Care · Pharmaceuticals · US
$0.00
-86.67% today · -98.7% 1Y
Bright Green Corporation (OTCPK: BGXX.Q) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $38.23K and employs 5 people.
Over the last twelve months the share price has lost 98.7%, trading between 0.00 and 0.05.
Tweenvest scores Bright Green Corporation across four factors: quality 19/100. Its strongest factor is quality.
BGXX.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.23K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 133.55
- 52-week high
- $0.05
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 191.17M
- Employees
- 5
- Next earnings
- —
About Bright Green Corporation
Bright Green Corporation grows, manufactures, and sells cannabis and cannabis-related products legally under federal and state laws for research, pharmaceutical applications, and export. The company was incorporated in 2019 and is based in Fort Lauderdale, Florida.
- ISIN
- US10920G1004
- Founded
- 2019
- Listed since
- May 17, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,215.72 | -1.45% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.68 | -0.53% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.48 | -1.26% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.20 | -1.50% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.46 | -1.84% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.33 | -0.86% |
Figures last refreshed Aug 18, 2026.